Ruprecht Zierz

Title: Ruprecht Zierz: Innovator in Bispecific Antibody Constructs

Introduction

Ruprecht Zierz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibody constructs. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Zierz's latest patents focus on bispecific antibody constructs for CDH3 and CD3. The inventions relate to a bispecific antibody construct that includes a first human binding domain targeting human CDH3 on the surface of a target cell and a second binding domain that binds to human CD3 on the surface of a T cell. Additionally, the inventions provide a polynucleotide encoding the antibody construct, a vector containing the polynucleotide, and a host cell transformed or transfected with the polynucleotide or vector. Furthermore, the inventions outline a process for producing the antibody construct, its medical applications, and a kit that includes the antibody construct.

Career Highlights

Ruprecht Zierz has worked with prominent companies in the biotechnology sector, including Amgen Research (Munich) GmbH and Amgen Research GmbH. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Throughout his career, Zierz has collaborated with notable professionals in the field, including Bertram Weiss and Peter Kufer. These collaborations have likely enhanced the quality and impact of his inventions.

Conclusion

Ruprecht Zierz is a distinguished inventor whose work in bispecific antibody constructs showcases his commitment to advancing medical science. His contributions are poised to make a significant difference in therapeutic applications.